References |
1 |
Ciclesonide Drugs. 2004;64(5):511-9; discussion 520-1. doi: 10.2165/00003495-200464050-00005.
|
2 |
Deposition and metabolism of inhaled ciclesonide in the human lung Eur Respir J. 2010 Nov;36(5):1113-9. doi: 10.1183/09031936.00172309.
|
3 |
LC-HRMS/MS study of the prodrug ciclesonide and its active metabolite desisobutyryl-ciclesonide in plasma after an inhalative administration to horses for doping control purposes. Drug Test Anal. 2022 Feb;14(2):252-261. doi: 10.1002/dta.3174.
|
4 |
Visualizing the spatial localization of ciclesonide and its metabolites in rat lungs after inhalation of 1-m aerosol of ciclesonide by desorption electrospray ionization-time of flight mass spectrometry imaging. Int J Pharm. 2021 Feb 15;595:120241. doi: 10.1016/j.ijpharm.2021.120241.
|
5 |
In Vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices Biopharm Drug Dispos. 2006 May;27(4):197-207. doi: 10.1002/bdd.500.
|